Conference on 2nd Annual Smoking Cessation 2009

Navi Mumbai, India (PressExposure) October 06, 2008 -- is glad to announce a new Conference titled “Conference on 2nd Annual Smoking Cessation 2009”([]).

Background Info

Cigarette smoking is the leading source of preventable morbidity and premature mortality worldwide. - IMS Health

Where the product market is advancing in both mechanism and drug delivery, smoking cessation is and will continue to be high demand due to anti-smoking legislation and bans over the world. Nicotine addiction continues to be one of the hardest addictions to break with everyone at one time being subject to second hand smoke the strain on the healthcare systems is showing with governments investigating health education and therapies

A wider range of products are needed to meet smokers' needs and addictions. In addition revolutionary technologies are driving the way forward in creating innovative and effective solutions, new Nicotine replacement therapies, which are expected to hit the market around late 2009.

Working together the healthcare authorities and pharmaceuticals companies are striding forward in the battle of the smoking epidemic.

By attending the conference you will:

Explore the stages leading pharmaceutical companies advancing within the anti-smoking market.

Discover the directions being taken to implement the dangers of Nicotine addiction in secure environments and hard to reach groups.

Examine potential market opportunities for new anti-smoking products.

Gain knowledge of forthcoming treatments and future of Nicotine Replacement therapy.

Asses the importance of implementing new health guidelines to educate the younger generation and passive smoking with in our worldwide communities

Key speakers

Dr Raafat Fahim, Chief Executive Officer, Nabi Biopharmaceuticals

Mark Tucker, Chief Executive Officer, G-Nostics

Dr Robert Walton, Department of Clinical Pharmacology, Oxford University

Richard Lawrence, OTC Business Line Manager, IMS Health

Lena Degling Wikingsson, Chief Executive Officer, Independent Phamaceutica

Qaim Zaidi, Ethic Strategy Coordinator, British Heart Foundation

Trevor Van Mierlo, Chief Executive Officer, V-CC Systems

Dr Martin Ledson, Consultant Chest Physician, Liverpool Heart and Chest Hospital

Dr Marcus Munafo, Department of Experimental Psychology, University of Bristol

Trish Jones, Smoking Advisor, Liverpool Heart and Chest Hospital

Scott Bryson, Lead Pharmaceutical Public Health, NHS Greater Glasgow & Clyde Pharmacy

Dr Su Wang, Group Head of Health, Royal Mail Group

Who will be there? VPs, Directors, Heads and Managers of:

Smoking Cessation/Anti- Smoking Products

Outcomes Research

Business Development

Clinical Trials

Drug Delivery

Product development



Product Management

Regulator Organisers

Clinical Pharmacology

Projected Management

Scientific Affairs

Healthcare Professionals

For further information kindly visit: []

OR Contact us at

Bharat Book Bureau 207, Hermes Atrium, Sector 11, PO Box.54, CBD Belapur, Navi Mumbai - 400 614, India. Phone: +91 22 2757 8668 / 2757 9438 Fax: +91 22 2757 9131 E-mail: Website:

About Bharat Book Bureau

Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.

Press Release Source:

Press Release Submitted On: October 03, 2008 at 5:36 am
This article has been viewed 35751 time(s).